Pregabalin Tablet, Film Coated, Extended Release
Product Images NDC 72205-077

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 72205-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pregabalin-er-tablets-165mg-30s-container-label (Pregabalin Er Tablets 165mg 30s Container Label)

Pregabalin Extended-Release Tablets 165 mg label for a 30-tablet package. The label includes storage instructions, dosage directions, and manufacturer information, indicating MSN Laboratories Private Limited as the manufacturer and Novadoz Pharmaceuticals LLC as the distributor.*

FDA Label Image

Pregabalin-er-tablets-330mg-30s-container-label (Pregabalin Er Tablets 330mg 30s Container Label)

Label for Pregabalin Extended-Release Tablets, 330 mg oral film-coated extended-release tablets by Novadoz Pharmaceuticals LLC. The label includes dosage strength, storage instructions, manufacturing and distributor information, and a barcode. The package contains 30 tablets.*

FDA Label Image

Pregabalin-er-tablets-82-5mg-30s-container-label (Pregabalin Er Tablets 82 5mg 30s Container Label)

Label for Pregabalin Extended-Release Tablets, 82.5 mg, film-coated and oral dosage form. The package contains 30 tablets and is distributed by Novadoz Pharmaceuticals LLC. The label includes storage instructions, manufacturer details (MSN Laboratories Private Limited), and a note for pharmacists to dispense the Medication Guide with each prescription.*

FDA Label Image

Fig (Pregabalin Er Tablets Figure)

A line graph comparing the percent of patients improved versus percent improvement in pain from baseline for Pregabalin versus placebo. It shows two lines: a solid line for Pregabalin and a dashed line for placebo, indicating the efficacy differences in pain improvement between the two groups.*

FDA Label Image

Eq (Pregabalin Er Tablets Gault Eq)

A mathematical formula used to estimate creatinine clearance (CLCr), incorporating patient age in years, weight in kilograms, serum creatinine in mg/dL, and a factor for female patients (0.85). The equation adjusts for kidney function assessment relevant to dosing or clinical decisions.*

FDA Label Image

Str (Pregabalin Er Tablets Structure)

Chemical structure of pregabalin depicting its molecular arrangement, including an amino group, carboxylic acid group, and a branched carbon chain. This structure corresponds to the active ingredient pregabalin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.